Skip to main content
Clinical Trials/NCT02682706
NCT02682706CompletedNot Applicable

Magnetic Resonance Imaging of Human Supraclavicular Brown Adipose Tissue - MIBAT Study

University Hospital, Basel, Switzerland2 sites in 1 country26 target enrollmentStarted: February 2016Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
26
Locations
2
Primary Endpoint
Correlation of scBAT volume and cold induced thermogenesis as determined by indirect calorimetry

Study Overview

Brief Summary

Brown adipose tissue (BAT) is unique in its capability to convert chemical energy directly into heat. Active BAT increases energy expenditure and can thereby counteract obesity and insulin resistance. Currently, the imaging method of choice to assess BAT morphology and function is 18F-FDG-PET/CT which is expensive and exposes patients or healthy volunteers to ionizing radiation, thus impeding larger prospective studies.

Magnetic resonance imaging (MRI) could constitute a suitable alternative and preliminary small-scale studies are promising.

The overall aim of this research proposal is to develop reliable magnetic resonance imaging techniques to facilitate the study of brown adipose tissue in human adults, specifically in the context of endocrine disease.

Specifically, investigators want to

  1. Develop a reliable MR imaging protocol for human BAT and compare BAT volume to cold induced nonshivering thermogenesis as a measure of BAT activity.
  2. Assess the intra-individual variance of BAT volume measured by MRI.
  3. Evaluate direct measurement of BAT temperature by functional MRI.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 50 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Healthy volunteers
  • •Age 18-40 years
  • •Body mass index (BMI): 17.5-27 kg/m²

Exclusion Criteria

  • •known concomitant disease influencing thyroid hormone metabolism
  • •severe diseases: chronic heart failure, liver cirrhosis, kidney failure, active cancer
  • •known hypersensitivity to cold, e.g. primary or secondary Raynaud's syndrome
  • •abuse of alcohol or illicit drugs
  • •Women who are pregnant or breast feeding
  • •Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant
  • •Previous enrolment into the current study
  • •implanted device not compatible with MRI, e.g. pace maker

Outcomes

Primary Outcomes

Correlation of scBAT volume and cold induced thermogenesis as determined by indirect calorimetry

Time Frame: both measurements within 2 weeks

measurement of scBAT volume and measurement of cold induced thermogenesis as determined by indirect calorimetry, both values measured in a timeframe of two weeks

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
University Hospital, Basel, Switzerland
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials